期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 19, 页码 8418-8428出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm300836n
关键词
-
资金
- Hungarian Scientific Research Fund [OTKA CK-77515]
- [TAMOP-4.2.1./B-09/1/KONV-2010-0007]
Endomorphins (EM-1 and EM-2) are selective, high affinity agonists of the mu-opioid (MOP) receptor, an important target in pain regulation. Their clinical use is impeded by their poor metabolic stability and limited entry to the central nervous system. In this study, the Pro(2) residue of EM-2 was modified systematically through substitution by hydroxyproline (Hyp), (S)-beta-homoproline beta Pro), 2-amino-cyclopentene-1-carboxylic acid (Delta Acpc), or 2-aminocyclohexene-1-carboxylic acid (Delta Achc) to obtain stable MOP active compounds. Both Hyp(2) and beta Pro(2) substitution decreased receptor affinity. Analogues incorporating alicyclic beta-amino acids exhibited diverse receptor binding properties, depending on the configuration of the substituent side-chain. (1S,2R)Delta Acpc(2)-EM-2 was shown to have MOP affinity and selectivity comparable to those of EM-2 and proved to act as agonist while being resistant to proteolysis. NMR and molecular dynamics (MD) studies revealed that bent backbone structures are predominant in the most potent analogues, while their presence is less pronounced in ligands of lower receptor affinity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据